Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Vaccines|July 27, 2024
Clinical and Diagnostic Features of Post-Acute COVID-19 Vaccination Syndrome (PACVS)Anna Katharina Mundorf, Amelie Semmler, Harald Heidecke, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 21, 2022
Low Concentrations of C5a Complement Receptor Antibodies Are Linked to Disease Activity and Relapse in Antineutrophil Cytoplasmic Autoantibody-Associated VasculitisSebastian Klapa, Antje Müller, Andreas Koch, et al.
Frontiers in Bioscience (Landmark Edition)|May 29, 2019
Regulatory antibodies against GPCR in women ten years after early-onset preeclampsiaAnna Birukov, Hella E C Muijsers, Harald Heidecke, et al.
International Journal of Molecular Sciences|April 12, 2022
Molecular Effects of Auto-Antibodies on Angiotensin II Type 1 Receptor Signaling and Cell ProliferationAurélie Philippe, Gunnar Kleinau, Jason Jannis Gruner, et al.
Vaccines|November 25, 2023
Chronic Fatigue and Dysautonomia following COVID-19 Vaccination Is Distinguished from Normal Vaccination Response by Altered Blood MarkersAmelie Semmler, Anna Katharina Mundorf, Anna Sabrina Kuechler, et al.
The American Journal of Pathology|November 5, 2002
Immunosuppressive treatment protects against angiotensin II-induced renal damageDominik N Muller, Erdenechimeg Shagdarsuren, Joon-Keun Park, et al.
Molecular Neurodegeneration|November 16, 2014
Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's diseaseDe-Hyung Lee, Harald Heidecke, Alexandra Schröder, et al.
International Journal of Molecular Sciences|January 11, 2022
Autoantibodies Targeting AT<sub>1</sub>- and ET<sub>A</sub>-Receptors Link Endothelial Proliferation and Coagulation via Ets-1 Transcription FactorRusan Catar, Melanie Herse-Naether, Nan Zhu, et al.
Pageof 11